Maximum Dose of Nortriptyline
The maximum recommended daily dose of nortriptyline is 150 mg/day, with doses above this threshold not recommended due to increased risk of adverse effects without additional therapeutic benefit. 1
FDA-Approved Maximum Dosing
The FDA drug label explicitly states that doses above 150 mg per day are not recommended 1. When doses above 100 mg daily are administered, plasma levels should be monitored and maintained in the optimum therapeutic range of 50-150 ng/mL 1.
Context-Specific Dosing Considerations
Standard Adult Dosing
- Typical maximum: 150 mg/day in divided doses or once daily 2
- Start at 25 mg 3-4 times daily and titrate gradually 1
- The total daily dose may be given once daily as an alternate regimen 1
Elderly Patients
- Maximum: 40 mg per day (given twice daily) 2
- Start at 10 mg at bedtime 2
- Lower doses are critical due to higher risk of adverse effects, particularly anticholinergic effects and orthostatic hypotension 3
- Higher plasma concentrations of the active metabolite 10-hydroxynortriptyline occur in elderly patients, potentially increasing cardiotoxicity risk even when parent drug levels are therapeutic 1
Neuropathic Pain Management
For neuropathic pain conditions, the maximum dose aligns with depression treatment:
- Goal dosage: 75-150 mg or 1-1.5 mg/kg at bedtime 4
- Maximum: 150 mg/day 5
- Slow titration (10-25 mg increments every 2 weeks) is better tolerated 4
- Requires 6-8 weeks with at least 2 weeks at maximum tolerated dosage for adequate trial 5
Critical Safety Monitoring
Therapeutic Drug Monitoring
Plasma level monitoring becomes mandatory above 100 mg/day 1. The therapeutic window is narrow:
- Optimal range: 50-150 ng/mL 2, 1
- Concentrations above 150 ng/mL are associated with increased adverse effects without improved efficacy 1
- If blood concentration of active medication plus metabolite is <100 ng/mL, continue titration with caution 5
Cardiovascular Concerns
A large retrospective study demonstrated increased risk of sudden cardiac death with TCA doses >100 mg/day 6. Therefore:
- Obtain baseline ECG, especially in patients with cardiovascular disease or elderly patients 6
- Do not use if PR or QTc interval is prolonged 6
- Monitor for orthostatic hypotension, particularly in geriatric patients 1
Common Pitfalls to Avoid
Exceeding 150 mg/day: No evidence supports efficacy beyond this dose, and adverse effects increase substantially 1
Inadequate monitoring above 100 mg/day: Plasma level monitoring is not optional at higher doses—it's required for safe prescribing 1
Using standard adult doses in elderly patients: The maximum of 40 mg/day in elderly patients is based on altered pharmacokinetics and increased sensitivity to adverse effects 2
Rapid titration: Slow dose escalation (10-25 mg increments every 2 weeks) significantly improves tolerability 4
Ignoring pharmacogenetic factors: CYP2D6 poor metabolizers require dose reductions or alternative medications due to dramatically elevated plasma levels 7, 8